<DOC>
	<DOCNO>NCT02242760</DOCNO>
	<brief_summary>This randomize , multi-center , double-blinded study subject moderate severe acne vulgaris . Subjects eligible enroll treat twice daily 2 concentration topical drug development vehicle . Subjects treat 12 week .</brief_summary>
	<brief_title>P2 Multi-center Study SB204 Gel Treatment Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Moderate severe acne 2570 noninflammatory lesion Baseline 2040 inflammatory lesion Baseline Subjects know allergy component test material vehicle Women pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>acne</keyword>
</DOC>